Litcius/Paper detail

OP0115 EFFICACY AND SAFETY OF ABBV-3373, A NOVEL ANTI-TNF GLUCOCORTICOID RECEPTOR MODULATOR ANTIBODY DRUG CONJUGATE, IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: A PHASE 2A PROOF OF CONCEPT STUDY

Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka‐Sienkiewicz, Timothy R. D. J. Radstake, S. Chen, Dilek Arikan, H. Küpper, Howard Amital

2021Annals of the Rheumatic Diseases12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRheumatoid arthritisInternal medicineClinical endpointAdalimumabPlaceboMethotrexateClinical trialPathologyAlternative medicineMonoclonal and Polyclonal Antibodies ResearchSystemic Lupus Erythematosus ResearchBiosimilars and Bioanalytical Methods